LOCANABIO
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.
LOCANABIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.locanabio.com
Total Employee:
11+
Status:
Active
Contact:
858.285.4000
Email Addresses:
[email protected]
Total Funding:
155.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acumen Pharmaceuticals
Acumen is developing targeted therapies for the safe and effective treatment of Alzheimer’s Disease and related neurodegenerative diseases.
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Jaguar Gene Therapy
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
UCB Ventures
UCB Ventures investment in Series B - Locanabio
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Locanabio
Acuta Capital Partners
Acuta Capital Partners investment in Series B - Locanabio
GV
GV investment in Series B - Locanabio
Invus
Invus investment in Series B - Locanabio
SVB Securities
SVB Securities investment in Series B - Locanabio
Vida Ventures
Vida Ventures investment in Series B - Locanabio
RA Capital Management
RA Capital Management investment in Series B - Locanabio
Lightstone Ventures
Lightstone Ventures investment in Series B - Locanabio
Temasek Holdings
Temasek Holdings investment in Series B - Locanabio
Key Employee Changes
Official Site Inspections
http://www.locanabio.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.01 K
- Host name: 230.121.231.35.bc.googleusercontent.com
- IP address: 35.231.121.230
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
